Skip to content

The effect of herbal and animal based omega-3 fatty acids supplementation on gestational diabetes

Metabolic response to herbal and animal based omega-3 fatty acids supplementation in women with gestational diabetes

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016041612438N20
Enrollment
105
Registered
2016-04-28
Start date
2016-04-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational diabetes. Diabetes mellitus in pregnancy, unspecified

Interventions

Intervention 1: Intervention group:Flax seed oil omega-3 pearl, 2 times per daily, for 6 weeks orally. Intervention 2: Intervention group:Fish oil omega-3 pearl, 2 times per daily, for 6 weeks orally.
Treatment - Drugs
Placebo
Intervention group:Flax seed oil omega-3 pearl, 2 times per daily, for 6 weeks orally.
Intervention group:Fish oil omega-3 pearl, 2 times per daily, for 6 weeks orally.
Control group:placebo pearl, 2 times per daily, for 6 weeks orally.

Sponsors

Barij Research Center of Medicinal Herbs
Lead Sponsor
Vice chancellor for research of Kashan University of Medical Science
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Pregnant women aged 18-40 years; diagnosed with GDM at 24-28 week gestation. Exclusion criteria: The use of substitute treatments including hormone or vitamin supplements; patients with pre-eclampsia; complete bed rest (CBR); intra uterine fetal death (IUFD); placenta abruption; preterm delivery.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Hs-CRP. Timepoint: Baseline and End-of-tria. Method of measurement: blood sample.;Insulin. Timepoint: Baseline and End-of-tria. Method of measurement: blood sample.;Insulin resistance. Timepoint: Baseline and End-of-tria. Method of measurement: blood sample.;Fasting plasma glucose. Timepoint: Baseline and End-of-tria. Method of measurement: blood sample.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.M.Taghizadeh

Kashan University of Medical Sciences

mohsenta44@yahoo.com+98 31 5554 0021

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026